Abstract
The present study explored the possible relationships between impulsivity, gender, and a peripheral serotonergic marker, the platelet serotonin (5-HT) transporter (SERT), in a group of 32 healthy subjects. The impulsivity was measured by means of the Barratt Impulsivity Scale, version 11 (BIS-11), a widely used self-report questionnaire, and the platelet SERT was evaluated by means of the specific binding of 3H-paroxetine (3H-Par) to platelet membranes, according to standardized protocols. The results showed that women had a higher BIS-11 total score than men, and also higher scores of two factors of the same scale: the motor impulsivity and the cognitive complexity. The analysis of the correlations revealed that the density of the SERT proteins, as measured by the maximum binding capacity (Bmax) of 3H-Par, was significantly and positively related to the cognitive complexity factor, but only in men. Men showed also a significant and negative correlation with the dissociation constant, Kd, of (3H-Par) binding, and the motor impulsivity factor. These findings suggest that women are generally more impulsive than men, but that the 5-HT system is more involved in the impulsivity of men than in that of women.
Keywords: impulsivity, gender, serotonin transporter, Barratt Impulsivity Scale, platelets, 3H-paroxetine
Introduction
The brain serotonin (5-HT) system plays an important role in the modulation of different functions and behaviors including appetite, sleep, memory and learning, mood, sexuality.1,2 However, on the basis of a wealth of preclinical and clinical observations,3–8 one of the most intriguing suggestions regarding the general role of 5-HT in the central nervous system (CNS) is that it might serve as a “modulator” of impulsivity and aggression.9–13
Several studies, employing different means to reduce the functionality of 5-HT, generally led to increased aggressive behaviors in animal models.14,15 In humans, autopsies carried out on suicide cases revealed abnormalities of different serotonergic parameters, such as decreased 5-HT levels,16,17 increased and reduced density of 5-HT2A and 5-HT1A receptors, respectively.17,18 Furthermore, a localized reduction of the 5-HT transporter (SERT) binding in the ventral prefrontal cortex, or fewer SERT mRNA expressing neurons were detected in the dorsal raphe nuclei of suicide victims, as compared with individuals with other disorders.16,19,20
Reduced concentrations of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of 5-HT, have been reported in the cerebrospinal fluid (CSF) of violent suicide attempters21,22 and especially in those who had committed it by violent means.23 The link between reduced CSF 5-HIAA and aggression has been subsequently supported by the observation of an inverse relationship with measures of impulsive aggression in male personality-disordered subjects,24,25 male violent offenders,3 or alcoholics.26,27 A similar relationship has been demonstrated between hormonal responses to acute serotonergic challenges and measures of impulsive aggression in personality-disordered subjects28–34 or healthy volunteers.35–38
In spite of these intriguing suggestions, a direct evidence of a link between the serotonergic system and impulsivity is still lacking, especially in healthy subjects. This is also due to intrinsic problems of research on this topic: first, the definition of impulsivity, for which no general agreement exists. An exhaustive definition is that given by the International Society for Research on Impulsivity (ISRI), which considers it as “a human behavior without adequate thought, the tendency to act with less forethought than do most individuals of equal ability and knowledge, or a predisposition toward rapid, unplanned reactions to internal or external stimuli without regard to negative consequences of these reactions”. Second, the assessment of impulsivity, which might permit to compare different studies. One of the most used and validated instruments is the so-called “Barratt Impulsivity Scale”, which is the results of decades of efforts and modifications until the latest version 11 (BIS-11)39 and considers impulsivity as a trait influenced by temperament and, as such, heritable and widely distributed in the population.40,41 Third, the availability of peripheral models of the serotonergic system, which should be reliable, easy to obtain, relatively safe and to be applied routinely in large samples. The SERT present in platelets fulfills all these requirements, especially after the demonstration of its identity with the same structure expressed in the CNS.42,43 A reduced density of platelet SERT was reported in individuals with personality disorders and aggressive behavior and in suicide attempters.44,45 Others46 reported a relationship between the short variant of the SERT promoter polymorphism (SLC6A4*C), a blunted fenfluramine-induced prolactin release and aggressive impulsivity, in a group of abstinent alcoholic patients and healthy volunteers, while suggesting that this genotype would contribute to altered serotonergic regulation of emotions. Previously, the same polymorphism was found to be linked to the two anxiety-related sub-dimensions of harm avoidance,47 and to increased neuroticism (which includes impulsivity) on a personality inventory and decreased agreeableness in general population samples.48,49
Given the paucity of available information, therefore, the aim of this study was to explore and compare impulsivity in a group of healthy individuals of both sexes, as well as to investigate the possible relationships between the platelet SERT and impulsivity characteristics. The platelet SERT was evaluated by means of the specific binding of 3H-paroxetine (3H-Par), one of the most selective ligands to label it, and impulsivity was assessed by means of the BIS-11 questionnaire.
Materials and methods
Subjects
Thirty-two drug-free volunteers of both sexes (15 men and 17 women, aged between 27 and 51 years, mean ± standard deviation [SD]: 36 ± 7) were included in the study. They had no family or personal history of any major psychiatric disorder, as assessed by a psychiatric interview, carried out by a senior psychiatrist (DM) by means of the SCID.50 They were recruited amongst medical and nursing staff at the Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Italy. All subjects were free of any physical illness, as documented by a general check-up and by the normal blood and urine tests. All were psychotropic drug-free, none were heavy smokers or belonged to HIV-risk groups. They all gave their informed written consent to participate in the study, which was approved by the Ethics Committee of Pisa University.
Impulsivity assessment
The impulsivity was assessed by means of the BIS-11 questionnaire validated into Italian.51
The BIS-11 is a self-report scale developed to measure impulsivity as a stable characteristic, composed by 30 items, which are answered on a four-point scale; items are scored 1, 2, 3, 4 where 4 indicates the most impulsive response: the higher the total scores for all items, the higher the level of impulsivity. The total score ranges between 30 and 120, with no established cut-off point and is the result of the sum of three different subscales: attentional (rapid shifts of attention and impatience with complexity), motor (impetuous action), and nonplanning (lack of future orientation) impulsivity. In addition, the 30 items form six factors determined by principal component analyses: attention, motor impulsivity, self-control, cognitive complexity, perseverance, and cognitive instability.
Preparation of platelet membranes and 3H-Par binding assay
Twenty-five ml of blood was withdrawn from fasting subjects between 8:00 and 9:00 am in the months of January and February to avoid circadian or seasonal rhythms, into plastic tubes containing 5 mL of anticoagulant (sodium citrate, 2.2%, and citric acid, 1.2%). Platelet-rich plasma was obtained by low-speed centrifugation (1,500 g for 15 min at 23°C). Platelets were precipitated from platelet-rich plasma by centrifugation at 1500 g for 15 min at 23°C and then stored at −80°C until assay, which was performed within one week. At the time of assay, platelets were washed in 10 mL of ice-cold 50 mmol/L Tris-HCl buffer (pH 7.4) and were centrifuged at 10,000 g for 10 min at 4°C. The resulting pellet was homogenized by an Ultraturrax homogenizer in 10 volumes of 5 mmol/L Tris-HCl buffer (pH 7.4) and were centrifuged at 30,000 g for 10 min at 4°C. The supernatant was discarded, and the final membrane pellet was re-suspended in the assay buffer (50 mmol/L Tris-HCl, 120 mmol/L NaCl and 5 mmol/L KCl, pH 7.4), and homogenized by an Ultraturrax homogenizer. The binding of 3H-Par to SERT on platelet membranes was determined according to the method of Marazziti and colleagues.52 The 3H-Par binding assays were performed in an incubation mixture consisting of 100 μL of platelet membranes (50–100 μg protein/tube), 50 μl of 3H-Par (Perkin-Elmer, Life Science, Milan, Italy; specific activity: 15.5 Ci/mmol) at concentrations ranging between 0.4 and 40 nmol/L, and 1850 μL of assay buffer. Specific binding was estimated as the binding remaining in the presence of 10 μmol/L fluoxetine (kindly provided by Eli-Lilly, Indianapolis, IN), used as the unlabeled competitor for SERT binding site. All samples were assayed in duplicate and incubated at 22°C for one hour. The reaction was then halted by adding 5 mL of cold assay buffer, followed by immediate filtration under vacuum through glass fiber filters GF/C (Whatman International, Maidstone, UK). The filters were washed three times with 5 mL of the assay buffer and dried, and the SERT-bound radioactivity trapped on the filters was counted in 4 mL of scintillation fluid by a scintillation spectrometry counter 1600 TR (Packard Bioscience, Groningen, The Netherlands). Protein concentration was determined according to the method of Lowry, as modified by Peterson.53
Statistical analyses
Equilibrium-saturation binding data, the maximum binding capacity (Bmax, fmol/mg protein) and the dissociation constant (Kd, nM) were analyzed by means of iterative curve-fitting computer programmes EBDA [Biosoft, Cambridge, UK].
The differences in binding parameters or BIS total or subscale scores between women and men were analyzed by means of the Student’s t-test.
The possible effects of age and sex on biological parameters were investigated by means of the analysis of covariance, while the correlations between variables were explored using the Pearson method, all with SPSS software (version 12.1; SPSS Inc, Chicago, IL, USA).
Results
The Bmax (mean ± SD, fmol/mg protein) and Kd (mean ± SD, nM) values were 1135 ± 119 and 0.095 ± 0.02, with no difference between women and men (Table 1). The BIS total score in all subjects was 55.1 ± 5.92, significantly higher in women than in men (58.76 ± 6.9 vs. 51.45 ± 4.94, t = −3.034, P = 0.005). In addition, the following factor scores were also higher in women than in men: motor impulsivity (t = −3.004, P = 0.006) and cognitive complexity (t = −2.096, P = 0.046).
Table 1.
3H-Par binding parameters (Bmax, mean ± SD, fmol/mg prot.; Kd, mean ± SD, NM) and BIS-11 total, subscale and factor scores (mean ± SD) in men and women
| Men | Women | ||
|---|---|---|---|
| 3H-Par binding parameters | Bmax | 1135 ± 127 | 1137 ± 111 |
| Kd | 0.094 ± 0.02 | 0.096 ± 0.03 | |
| BIS-11 total score | 51.45 ± 4.94 | 58.76 ± 6.9* | |
| BIS-11 subscale | Attentional | 18.36 ± 2.87 | 20.29 ± 2.86 |
| Motor | 17.18 ± 1.72 | 21.17 ± 2.89 | |
| Nonplanning | 15.9 ± 1.86 | 17.29 ± 3.78 | |
| BIS-11 factor | Attention | 7.09 ± 1.3 | 7.76 ± 2.35 |
| Motor impulsivity | 11.54 ± 2.06 | 14.7 ± 3.05** | |
| Self-control | 11.18 ± 2.08 | 12.58 ± 3.1 | |
| Cognitive complexity | 11.27 ± 1.79 | 12.52 ± 1.37*** | |
| Perseverance | 5.63 ± 1.12 | 6.47 ± 1.12 | |
| Cognitive instability | 4.72 ± 1.27 | 4.7 ± 1.44 |
Notes:
Significant: t = −3.034, P = 0.005;
Significant: t = −3.004, P = 0.006;
Significant: t = −2.096, P = 0.046.
The correlation analysis showed that the Bmax was significantly and positively related to the cognitive complexity factor of the whole sample (Pearson correlation = 0.378, P = 0.047), however, when distinguishing between the two sexes, it emerged that it was present only in men (Pearson correlation = 0.628, P = 0.039), while it was lacking in women (Figure 1a). Men showed also a significant and negative correlation between the Kd and the motor impulsivity factor (Pearson correlation = −0.673, P = 0.023) (Figure 1b).
Figure 1.
A) Positive correlation between the Bmax and the cognitive complexity factor in men (Pearson correlation = 0.378, P = 0.006). B) Negative correlation between the Kd and the motor impulsivity factor in men (Pearson correlation = −0.673, P = 0.023).
Discussion
The present study explored and compared the possible differences in impulsivity characteristics, assessed by the BIS-11 questionnaire, in a group of healthy volunteers of both sexes, as well as the eventual correlations with the platelet SERT, evaluated by means of the 3H-Par binding parameters (the maximum binding capacity, Bmax, and the dissociation constant, Kd). Although the ensuing findings are affected by some limitations which should be acknowledged, such as the small sample size, the evidence that all subjects belonged to the same setting and had similar life-habits, and that impulsivity was assessed by a self-report scale only, factors that perhaps limit their generalizability, nevertheless they are intriguing. It should be noted, however, that rarely, both self-report and behavioral measures have been used together.54–56
First, the women of our sample showed a higher BIS-11 total score than men, and even the scores of two BIS-11 factors, the so-called “motor impulsivity” and “cognitive complexity”, were higher in women than in men. These findings would indicate that women are generally more impulsive than men, at least when considering impulsivity as a trait, construct at the basis of the BIS questionnaire. Most of the literature data are in disagreement with our observations, as men and women do not appear to be consistently different on impulsivity,39,56,57 or men had higher scores at the BIS-11 questionnaire.58 In addition, gender has been shown to modulate the link between impulsivity and some health-risk behaviors, such as nicotine use in women,59,60 or alcohol intake in both men and women.58,59,61,62
Second, the correlation analysis revealed that the Bmax of 3H-Par binding, which is a measure of the number of the SERT proteins, was significantly and positively related to the BIS-11 cognitive complexity factor, but only in men. This means that the higher the density of the SERT proteins, the higher the score of the BIS-11 factor. The men of our sample showed also another significant, albeit negative, correlation between the motor impulsivity factor and the Kd, which is the inverse of the affinity constant, that is to say, when the Kd is low, the motor impulsivity increases, and viceversa. These findings are consistent with the results of a previous study reporting that increased platelet SERT affinity (low Kd) correlated with higher ratings of aggressive and externalising beahvior in childhood attention deficit/hyperactivity disorder.63 In addition, they can be considered in agreement with the general observations of disturbances of the serotonergic system, as shown blunted prolactin response to fenfluramine amongst male, but not female subjects with borderline personality disorder,29,34,64–67 or lower prolactin or cortisol responses in healthy men,36–38,68,69 or increased platelet 5-HT content in impulsive adolescents.70 Moreover, in impulsive men the blunted prolactin response has been related to the short variant of the SERT promoter,46 while in impulsive girls such a variant seems to predispose to higher sensitivity to environmental adversity.71 Taken together, these findings suggest that 5-HT is more implicated in impulsivity in men than in women. Interestingly, it has been reported that acute tryptophan depletion increases impulsive response style in men only, without affecting mood.72,73 Therefore, it seems that gender is an important factor in the modulation of 5-HT upon impulsivity.
In conclusion, the findings of the present study would suggest that impulsivity is a complex phenomenon, with multiple facets, and resulting from the interplay of different factors, in particular the 5-HT system, whose role on this behavior is strongly modulated by gender, although with no doubt other neurotransmitters are involved.13
Future studies should confirm or not our observations in larger sample of healthy subjects, as well as in patients with different impulse control disorders.
Footnotes
Disclosures
The authors report no conflicts of interest in this work.
References
- 1.Evenden JL. Varieties of impulsivity. Psychopharmacology. 1999;146:348–361. doi: 10.1007/pl00005481. [DOI] [PubMed] [Google Scholar]
- 2.Olivier B. Serotonin and aggression. Ann N Y Acad Sci. 2004;1036:382–392. doi: 10.1196/annals.1330.022. [DOI] [PubMed] [Google Scholar]
- 3.Linnoila M, Virkkunen M, Scheinin M, Nuutile A, Rimon R, Goodwin FK. Low cerebrospinal-fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 1983;33:2609–2614. doi: 10.1016/0024-3205(83)90344-2. [DOI] [PubMed] [Google Scholar]
- 4.Vergnes M, Depaulis A, Boehrer A. Parachlorophenylalanine-induced serotonin depletion increases offensive but not defensive aggression in male rats. Physiol Behav. 1986;36:653–658. doi: 10.1016/0031-9384(86)90349-5. [DOI] [PubMed] [Google Scholar]
- 5.Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry. 1997;54:1081–1088. doi: 10.1001/archpsyc.1997.01830240035005. [DOI] [PubMed] [Google Scholar]
- 6.Harrison AA, Everitt BJ, Robbins TW. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology. 1997;133:329–342. doi: 10.1007/s002130050410. [DOI] [PubMed] [Google Scholar]
- 7.Harrison AA, Everitt BJ, Robbins TW. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav Brain Res. 1999;100:99–112. doi: 10.1016/s0166-4328(98)00117-x. [DOI] [PubMed] [Google Scholar]
- 8.Fairbanks LA, Melega WP, Jorgensen MJ, Kaplan JR, McGuire MT. Social impulsivity inversely associated with CSF 5-HIAA and fluoxetine exposure in vervet monkeys. Neuropsychopharmacology. 2001;24:370–378. doi: 10.1016/S0893-133X(00)00211-6. [DOI] [PubMed] [Google Scholar]
- 9.Soubrié P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci. 1986;9:319–364. [Google Scholar]
- 10.Highley JD, Linnoila M. Low central nervous system serotonergic activity is trait like and correlates with impulsive behavior. Ann N Y Acad Sci. 1997;836:39–56. doi: 10.1111/j.1749-6632.1997.tb52354.x. [DOI] [PubMed] [Google Scholar]
- 11.Kalenscher T, Ohmann T, Güntürkün O. The neuroscience of impulsive and self-controlled decisions. Int J Psychophysiol. 2006;62(2):203–211. doi: 10.1016/j.ijpsycho.2006.05.010. [DOI] [PubMed] [Google Scholar]
- 12.Serretti A, Mandelli L, Lorenzi C, et al. Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms. Neuropsychobiology. 2006;53:9–16. doi: 10.1159/000089916. [DOI] [PubMed] [Google Scholar]
- 13.Pattij T, Vanderschuren LJ. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci. 2008;29(4):192–199. doi: 10.1016/j.tips.2008.01.002. [DOI] [PubMed] [Google Scholar]
- 14.Saudou F, Amara DA, Dierich A, et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science. 1994;265(5180):1875–1878. doi: 10.1126/science.8091214. [DOI] [PubMed] [Google Scholar]
- 15.Stark KL, Oosting RS, Hen R. Inducible knockout strategies to probe the functions of 5-HT receptors. Ann N Y Acad Sci. 1998;861:57–66. doi: 10.1111/j.1749-6632.1998.tb10173.x. [DOI] [PubMed] [Google Scholar]
- 16.Korpi ER, Kleinman JE, Goodman SI, et al. Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death. Arch Gen Psychiatry. 1986;43(6):594–600. doi: 10.1001/archpsyc.1986.01800060088011. [DOI] [PubMed] [Google Scholar]
- 17.Arango V, Underwood MD, Boldrini M, et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 2001;25(6):892–903. doi: 10.1016/S0893-133X(01)00310-4. [DOI] [PubMed] [Google Scholar]
- 18.Oquendo MA, Russo SA, Underwood MD, et al. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry. 2006;59(3):235–243. doi: 10.1016/j.biopsych.2005.06.037. [DOI] [PubMed] [Google Scholar]
- 19.Mann JJ, Henteleff RA, Lagattuta TF, Perper JA, Li S, Arango V. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites. J Neural Transm. 1996;103(11):1337–1350. doi: 10.1007/BF01271194. [DOI] [PubMed] [Google Scholar]
- 20.Arango V, Underwood MD, Mann JJ. Serotonin brain circuits involved in major depression and suicide. Prog Brain Res. 2002;136:443–453. doi: 10.1016/s0079-6123(02)36037-0. [DOI] [PubMed] [Google Scholar]
- 21.Asberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 1976;33(10):1193–1197. doi: 10.1001/archpsyc.1976.01770100055005. [DOI] [PubMed] [Google Scholar]
- 22.Mann JJ, Malone KM. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry. 1997;41(2):162–171. doi: 10.1016/s0006-3223(96)00217-x. [DOI] [PubMed] [Google Scholar]
- 23.Träskman-Bendz L, Asberg M, Schalling D. Serotonergic function and suicidal behavior in personality disorders. Ann N Y Acad Sci. 1986;487:168–174. doi: 10.1111/j.1749-6632.1986.tb27896.x. [DOI] [PubMed] [Google Scholar]
- 24.Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1(2):131–139. doi: 10.1016/0165-1781(79)90053-2. [DOI] [PubMed] [Google Scholar]
- 25.Brown GL, Ebert MH, Goyer PF, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry. 1982;139(6):741–746. doi: 10.1176/ajp.139.6.741. [DOI] [PubMed] [Google Scholar]
- 26.Limson R, Goldman D, Roy A, et al. Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Arch Gen Psychiatry. 1991;48(5):437–441. doi: 10.1001/archpsyc.1991.01810290049010. [DOI] [PubMed] [Google Scholar]
- 27.Virkkunen M, Goldman D, Linnoila M. Serotonin in alcoholic violent offenders. Ciba Found Symp. 1996;194:168–182. doi: 10.1002/9780470514825.ch10. [DOI] [PubMed] [Google Scholar]
- 28.Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989;46(7):587–599. doi: 10.1001/archpsyc.1989.01810070013002. [DOI] [PubMed] [Google Scholar]
- 29.Coccaro EF, Berman ME, Kavoussi RJ, Hauger RL. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry. 1996;40(3):157–164. doi: 10.1016/0006-3223(95)00398-3. [DOI] [PubMed] [Google Scholar]
- 30.Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry. 1997;154(10):1430–1435. doi: 10.1176/ajp.154.10.1430. [DOI] [PubMed] [Google Scholar]
- 31.Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res. 1997;73:1–2. 1–14. doi: 10.1016/s0165-1781(97)00108-x. [DOI] [PubMed] [Google Scholar]
- 32.Moss HB, Yao JK, Panzak GL. Serotonergic responsivity and behavioral dimensions in antisocial personalità disorder with substance abuse. Biol Psychiatry. 1990;28(4):325–338. doi: 10.1016/0006-3223(90)90660-t. [DOI] [PubMed] [Google Scholar]
- 33.O’Keane V, Moloney E, O’Neill H, O’Connor A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 1992;160:643–646. doi: 10.1192/bjp.160.5.643. [DOI] [PubMed] [Google Scholar]
- 34.Soloff PH, Kelly TM, Strotmeyer SJ, Malone KM, Mann JJ. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res. 2003;119(1–2):11–24. doi: 10.1016/s0165-1781(03)00100-8. [DOI] [PubMed] [Google Scholar]
- 35.Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The Temperament and Character Inventory (TCI): A guide to its development and use. St. Luise, MO: Center for Psychobiology of Personality, Washington University; 1994. [Google Scholar]
- 36.Cleare AJ, Bond AJ. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatry Res. 1997;69(2–3):89–95. doi: 10.1016/s0165-1781(96)03052-1. [DOI] [PubMed] [Google Scholar]
- 37.Evans J, Platts H, Lightman S, Nutt D. Impulsiveness and the pro-lactin response to d-fenfluramine. Psychopharmacology (Berl) 2000;149(2):147–152. doi: 10.1007/s002139900361. [DOI] [PubMed] [Google Scholar]
- 38.Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology. 2000;25(5):479–496. doi: 10.1016/s0306-4530(00)00004-4. [DOI] [PubMed] [Google Scholar]
- 39.Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768–774. doi: 10.1002/1097-4679(199511)51:6<768::aid-jclp2270510607>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- 40.Coccaro EF, Bergeman CS, McClearn GE. Heritability of irritable impulsiveness: a study of twins reared together and apart. Psychiatry Res. 1993;48(3):229–242. doi: 10.1016/0165-1781(93)90074-q. [DOI] [PubMed] [Google Scholar]
- 41.Livesley WJ, Jang KL, Vernon PA. Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry. 1998;55(10):941–948. doi: 10.1001/archpsyc.55.10.941. [DOI] [PubMed] [Google Scholar]
- 42.Lesch KP, Wolozin BL, Murphy DL, Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem. 1993;60(6):2319–2322. doi: 10.1111/j.1471-4159.1993.tb03522.x. [DOI] [PubMed] [Google Scholar]
- 43.Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD. Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci. 1995;15(2):1261–1274. doi: 10.1523/JNEUROSCI.15-02-01261.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Coccaro EF, Kavoussi RJ, Sheline YI, Lish JD, Csernansky JG. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry. 1996;53(6):531–536. doi: 10.1001/archpsyc.1996.01830060075010. [DOI] [PubMed] [Google Scholar]
- 45.Marazziti D, Dell’Osso L, Rossi A, et al. Decreased platelet [3H]paroxetine binding sites in suicide attempters. Psychiatry Res. 2001;103(2–3):125–131. doi: 10.1016/s0165-1781(01)00281-5. [DOI] [PubMed] [Google Scholar]
- 46.Reist C, Mazzanti C, Vu R, Tran D, Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet. 2001;105(4):363–368. doi: 10.1002/ajmg.1360. [DOI] [PubMed] [Google Scholar]
- 47.Mazzanti CM, Lappalainen J, Long JC, et al. Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry. 1998;55(10):936–940. doi: 10.1001/archpsyc.55.10.936. [DOI] [PubMed] [Google Scholar]
- 48.Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274(5292):1527–1531. doi: 10.1126/science.274.5292.1527. [DOI] [PubMed] [Google Scholar]
- 49.Greenberg BD, Li Q, Lucas FR, et al. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet. 2000;96(2):202–216. doi: 10.1002/(sici)1096-8628(20000403)96:2<202::aid-ajmg16>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- 50.First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I P, Version 20, 4 97 revision) New York, NY: Biometrics Research, New York State Psychiatric Institute; 1997. [Google Scholar]
- 51.Fossati A, Di Ceglie A, Acquarini E, Barratt ES. Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in nonclinical subjects. J Clin Psychol. 2001;57(6):815–828. doi: 10.1002/jclp.1051. [DOI] [PubMed] [Google Scholar]
- 52.Marazziti D, Rossi A, Gemignani A, et al. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology. 1996;34:184–187. doi: 10.1159/000119308. [DOI] [PubMed] [Google Scholar]
- 53.Peterson GL. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal Biochem. 1977;83:356–366. doi: 10.1016/0003-2697(77)90043-4. [DOI] [PubMed] [Google Scholar]
- 54.White JL, Moffitt TE, Caspi A, Bartusch DJ, Needles DJ, Stouthamer-Loeber M. Measuring impulsivity and examining its relationship to delinquency. J Abnorm Psychol. 1994;103(2):192–205. doi: 10.1037//0021-843x.103.2.192. [DOI] [PubMed] [Google Scholar]
- 55.Lane S, Cherek DR, Rhodes HM, Pietras CJ, Techeremissine OV. Relationships among laboratory and psychometric measures of impulsivity: implications in substance abuse and dependence. Addict Disord Their Treat. 2003;2:33–40. [Google Scholar]
- 56.Reynolds B, Ortengren A, Richards JB, de Wit H. Dimensions of impulsive behaviour: personality and behavioural measures. Pers Indiv Dif. 2006;40:305–315. [Google Scholar]
- 57.Feingold A. Gender differences in personality: a meta-analysis. Psychol Bull. 1994;116(3):429–456. doi: 10.1037/0033-2909.116.3.429. [DOI] [PubMed] [Google Scholar]
- 58.Stoltenberg SF, Batien BD, Birgenheir DG. Does gender moderate associations among impulsivity and health-risk behaviors? Addict Behav. 2008;33(2):252–265. doi: 10.1016/j.addbeh.2007.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Waldeck TL, Miller LS. Gender and impulsivity differences in licit substance use. J Subst Abuse. 1997;9:269–275. doi: 10.1016/s0899-3289(97)90021-3. [DOI] [PubMed] [Google Scholar]
- 60.Granö N, Keltikangas-Järvinen L, Kouvonen A, et al. Impulsivity as a predictor of newly diagnosed depression. Scand J Psychol. 2007;48(2):173–179. doi: 10.1111/j.1467-9450.2007.00566.x. [DOI] [PubMed] [Google Scholar]
- 61.Caspi A, Begg D, Dickson N, et al. Personality differences predict health-risk behaviors in young adulthood: evidence from a longitudinal study. J Pers Soc Psychol. 1997;73(5):1052–1063. doi: 10.1037//0022-3514.73.5.1052. [DOI] [PubMed] [Google Scholar]
- 62.Gerald MS, Higley JD. Evolutionary underpinnings of excessive alcohol consumption. Addiction. 2002;97(4):415–425. doi: 10.1046/j.1360-0443.2002.00023.x. [DOI] [PubMed] [Google Scholar]
- 63.Oades RD, Slusarek M, Velling S, Bondy B. Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): clinical versus experimental measures of impulsivity. World J Biol Psychiatry. 2002;3(2):96–100. doi: 10.3109/15622970209150607. [DOI] [PubMed] [Google Scholar]
- 64.Hollander E, Stein DJ, DeCaria CM, et al. Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry. 1994;151(2):277–280. doi: 10.1176/ajp.151.2.277. [DOI] [PubMed] [Google Scholar]
- 65.Stein DJ, Hollander E, DeCaria CM, Simeon D, Cohen L, Aronowitz B. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Biol Psychiatry. 1996;40(6):508–513. doi: 10.1016/0006-3223(95)00470-X. [DOI] [PubMed] [Google Scholar]
- 66.Martial J, Paris J, Leyton M, et al. Neuroendocrine study of serotonin function in female borderline personalità disorder patients: a pilot study. Biol Psychiatry. 1997;42(8):737–739. doi: 10.1016/s0006-3223(97)00295-3. [DOI] [PubMed] [Google Scholar]
- 67.New AS, Trestman RL, Mitropoulou V, et al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res. 1997;69(1):17–26. doi: 10.1016/s0165-1781(96)02784-9. [DOI] [PubMed] [Google Scholar]
- 68.Ruegg RG, Gilmore J, Ekstrom RD, et al. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biol Psychiatry. 1997;42(12):1123–1129. doi: 10.1016/s0006-3223(97)00009-7. [DOI] [PubMed] [Google Scholar]
- 69.Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF. Aggression, impulsivity, and central nervous system sero-tonergic responsivity in a nonpatient sample. Neuropsychopharmacology. 1998;19(4):287–299. doi: 10.1016/S0893-133X(98)00015-3. [DOI] [PubMed] [Google Scholar]
- 70.Askenazy F, Caci H, Myquel M, Darcourt G, Lecrubier Y. Relationship between impulsivity and platelet serotonin content in adolescents. Psychiatry Res. 2000;94(1):19–28. doi: 10.1016/s0165-1781(00)00124-4. [DOI] [PubMed] [Google Scholar]
- 71.Paaver M, Kurrikoff T, Nordquist N, Oreland L, Harro J. The effect of 5-HTT gene promoter polymorphism on impulsivity depends on family relations in girls. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1263–1268. doi: 10.1016/j.pnpbp.2008.03.021. [DOI] [PubMed] [Google Scholar]
- 72.Walderhaug E, Lunde H, Nordvik JE, Landrø NI, Refsum H, Magnusson A. Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berl) 2002;164(4):385–391. doi: 10.1007/s00213-002-1238-4. [DOI] [PubMed] [Google Scholar]
- 73.Walderhaug E, Magnusson A, Neumeister A, et al. Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol Psychiatry. 2007;62(6):593–599. doi: 10.1016/j.biopsych.2007.02.012. [DOI] [PubMed] [Google Scholar]

